Michael van Meter

Michael Van Meter serves as a Principal Scientist at Regeneron since August 2015, specializing in preclinical target discovery and development for hematological malignancies and certain solid tumors, alongside expertise in bispecific antibodies, antibody drug conjugates, and cellular therapies. Michael's prior experience includes a Postdoctoral Fellow role focusing on T-cell acute lymphoblastic leukemia at Regeneron, a Graduate Researcher role at the University of Rochester studying the biology of aging, and a Scientific Consultant position providing strategic services to grant-seeking clients. Additionally, Michael has a foundation in lipid and fat metabolism from a research technician position at Union College. Academic credentials include a PhD in Molecular Biology and an MBA from the University of Rochester, as well as a B.S. in Biochemistry from Union College.